| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2025 | 5 Feb 2025 |
| CHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter as well as nine months ended on 31st December 2024 along with the Limited Review Report thereon; 2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any. 1. Considered and approved Unaudited Financial Results for the Quarter and Nine Month ended 31st December, 2024 along with the Limited review report; 2. Other routine businesses with the permission of Chair (As Per BSE Announcement Dated on 14.02.2025) Extract of Unaudited Financial Results for the quarter and nine months ended 31st December, 2024 which has been published in the newspaper (As per BSE Announcement Dated on 15/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 5 Nov 2024 |
| CHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Result of the Company for the Quarter and Half Year ended on 30th September 2024; 2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any 1. Considered and approved Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2024 along with the Limited review report; 2. Other routine businesses with the permission of Chair. (As per BSE Announcement dated on 14/11/2024) | ||
| Board Meeting | 13 Aug 2024 | 3 Aug 2024 |
| CHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. To consider and approve the standalone Unaudited Financial Result of the Company for the Quarter ended on 30th June 2024; 2. Other matters as prescribed in the notice. 1. Reappointment of Mr. Sunil Choksi as Managing Director of company; 2. Reappointment of Mrs. Stela Choksi as Whole Time Director of the company. 1. Considered and approved Unaudited Standalone Financial Results for the Quarter ended 30th June, 2024 along with the Limited review report; 2. Decided the date for closure of Register of Members and share transfer Books of the Company which from Sunday 15th September, 2024 to Saturday 21st September, 2024 (both days inclusive) for the purpose of 31st Annual General Meeting; 3. Finalized the cut off date and remote e-voting period for the ensuing AGM; 4. Considered, Approved and Adopted the Boards Report and all the annexure including Corporate Governance Report and Management Discussion & Analysis Report (MDAR) for the Financial Year ended 31st March 2024; 5. Approved Notice of 31st Annual General Meeting and decided the date of 31st Annual General Meeting to be held on Saturday, the 21st day of September, 2024 at 11.00 A.M. through Video Conferencing (VC) or Other Audio-Visual Means (OAVM); 6. Other Business as mentioned in outcome (As per BSE Announcement Dated on 13/08/2024) | ||
| Board Meeting | 29 May 2024 | 21 May 2024 |
| CHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve 1. To consider and approve the standalone Audited Financial Result of the Company for the fourth Quarter and Year ended on 31st March 2024; 2. To appoint Internal Auditor of the Company for the Financial Year 2024-25; 3. To appoint Ms. Surabhi Agrawal Practicing Company Secretary as Secretarial Auditor of the Company for the Financial Year 2024-25; 4. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting which shall include at least one independent Director. If any. 1. Considered and approved Audited Standalone Financial Results for the Fourth Quarter as well as year ended 31st March, 2024 along with the Auditors Report thereon, Statement of Assets and Liabilities, and Cash Flow Statement; 2. Declaration regarding unmodified opinion of the Auditors on Annual Audited Financial Results of the Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015; 3. Other routine businesses with the permission of Chair Read less.. Considered and approved the Financial Result for the quarter and year ended 31.03.2024 (As Per BSE Announcement Dated on 29.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
